Tranzyme

^{, Nasdaq: TZYM}

Developing small molecule therapeutics to treat gastrointestinal disorders.

Industry: Health Care

First Day Return: 0.0%

TZYM

Developing small molecule therapeutics to treat gastrointestinal disorders.

IPO News for Tranzyme

Tranzyme prices IPO at $4, well below the original $11-$13 range 04/01/11
Tranzyme slashes estimated IPO price 04/01/11
Biotech Tranzyme sets terms for $60 million IPO 03/08/11

IPO Data
IPO Date	04/01/2011
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$54
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.tranzyme.com
Headquarters	Durham, NC, United States
Founded	1998
Employees at IPO	39

IPO News for Tranzyme

Tranzyme prices IPO at $4, well below the original $11-$13 range 04/01/11
Tranzyme slashes estimated IPO price 04/01/11
Biotech Tranzyme sets terms for $60 million IPO 03/08/11

Tranzyme (TZYM) Performance